Imunon, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-09-30 was -43.50K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-06-30 was 6.67K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2013-03-31 was 49.27K shares.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2013 was 12.43K shares, a 73.87% decline from fiscal 2012.
- Imunon, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2012 was 47.58K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | 12.43K shares 10-K · filed 2016-03-30 |
| 2013-09-30 | -43.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 21.25K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | 6.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 47.58K shares derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | 49.27K shares 10-Q · filed 2013-05-09 | |
| 2012-12-31 | 8.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | 47.58K shares 10-K · filed 2015-03-12 |
| 2012-09-30 | -17.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |